Zepbound (tirzepatide) 2.5 mg/0.5 mL is a prescription medication used for chronic weight management in adults with obesity or overweight (BMI ≥27 kg/m²) who have at least one weight-related condition (e.g., hypertension, type 2 diabetes).
Key Details:
-
Active Ingredient: Tirzepatide (a GLP-1 and GIP receptor agonist).
-
Dosage: 2.5 mg per 0.5 mL injection (starter dose for the first 4 weeks).
-
Administration: Subcutaneous (under the skin) once weekly.
-
Pen Design: Single-dose, pre-filled auto-injector.
Important Notes:
-
Titration Schedule: The 2.5 mg dose is the initial dose to reduce gastrointestinal side effects. It is typically increased every 4 weeks (5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg) based on tolerance and weight loss goals.
-
Side Effects: Common ones include nausea, diarrhea, vomiting, constipation, and abdominal pain. These often improve over time.
-
Storage: Refrigerate (2–8°C/36–46°F) before first use; after opening, it can be stored at room temperature (≤30°C/86°F) for up to 21 days.
-
Prescription Required: Available only with a doctor’s prescription.
Similar to Mounjaro:
Zepbound contains the same ingredient as Mounjaro (tirzepatide) but is FDA-approved specifically for weight loss, whereas Mounjaro is approved for type 2 diabetes.
If you have specific questions about usage, side effects, or insurance coverage, consult your healthcare provider or pharmacist.
Would you like additional details on dosing, cost, or comparisons with other weight-loss medications?
Reviews
There are no reviews yet.